Our Deals

• 2023.01.17Grandway Advised Kuncai Technology on Non-public offering Approved by Issuance Appraisal Committee of CSRC
• 2023.01.17Grandway Advised Capital Securities on IPO Project Approved by CSRC
• 2022.11.24Grandway Advised PCI Technology on Investing in Unity China, the Global “Metaverse” Leader
• 2022.11.24Grandway Advised Zbit on Listing on the SSE STAR Market
• 2022.11.24Grandway Advised Yangtze on the IPO Project Approved by SHSE
• 2022.11.24Grandway Advised Dioo Microcircuits on Listing on the SSE STAR Market
• 2022.11.24Grandway Advised Baoding Technology on the Major Asset Restructuring Unconditionally Approved
• 2022.11.24Grandway Advised Mankun Technology on Listing on the ChiNext of SZSE
• 2022.11.24Grandway Advised Shandong Pharmaceutical Glass on Its PIPE Financing Approved by CSRC
• 2022.11.24Grandway Advised Tinci Materials on Public Offering of Convertible Bonds Approved by CSRC
• 2022.11.24Grandway Advised Sinomicro Semi-conductor on Listing on the SSE STAR Market
• 2022.11.16Grandway Advised Ningbo Shanshan on the First Issue of GDRs and Listing on SWX
• 2022.11.16Grandway Advised Yitoa Intelligent Control on Application for Issuance of Shares to Specific Investors by Simplified Procedure Approved by CSRC
• 2022.11.16Grandway Advised Lixin Energy on Listing on SZSE
• 2022.11.16Grandway Advised Nanda Optoelectronics on Convertible Bond Issuance Approved by SZSE
• 2022.11.16Grandway Advised Lyric on Convertible Bond Issuance Approved by SHSE
• 2022.11.16Grandway Advised Hengbo on IPO Project Approved by SZSE
• 2022.11.16Grandway Advised ENN on Restructuring Project Approved by the Restructuring Committee of CSRC
• 2022.11.16Grandway Advised Xinbida on Angel Round Financing
• 2022.11.16Grandway Advised Noah Medical on Introducing Strategic Investment from HONG KONG XINSHIJIE GROUP